Shilpa Medicare said that ANVISA-Brazil successfully completed good manufacturing practice (GMP) inspection at its subsidiary, Shilpa Pharma Lifesciences’ Active Pharmaceutical Ingredient (API) manufacturing facility, Unit II situated in Karnataka.

Shilpa Medicare subsidiary’s Karnataka facility clears GMP inspection

Upcoming results : Kesoram Industries, Tata Elxsi.

Stock Alert: JSW Steel, Delta Corp, Rail Vikas Nigam, Adani Power, Shilpa Medicare

Stocks In Focus | Shilpa Medicare expects order for 5 million tablets before June 2025 & 15 million before Dec 2025 after a key CDMO customer shows positive clinical results for a kidney disease drug. ekta_batra.

#shilpamedicare #shilpamedicarestock #cnbctv18 #businessnews #businessnewstoday #businessnewsinenglish #sharemarkettoday 

🔴CNBC TV18 LIVE TV: https://youtube.com/live/P857H4ej-MQ
SUBSCRIBE to our Channel: https://bit.ly/3nvEcxf
---------------------------------------------------------------------------------------------------------------------
👑 Check Out Top CNBC TV18 Playlist Videos: 
   
🔹Lok Sabha Elections 2024: https://www.youtube.com/playlist?list=PLjq9mRS1PfGC0rKWJ57LWAs_ytML7x4CD

🔹CNBC TV18 Digital Podcast: https://www.youtube.com/playlist?list=PLjq9mRS1PfGCUcGVQvYyDQ6VVHoo3ZDKJ

🔹Sounding Board: https://www.youtube.com/playlist?list=PLjq9mRS1PfGBbB2dV2tyHdzx_k9EqvVEm 

🔹International Videos: https://www.youtube.com/playlist?list=PLjq9mRS1PfGDZ-Dkz-VpCDqqmWThJ3YJw

🔹CNBC TV18 Market Cafe: https://www.youtube.com/playlist?list=PLjq9mRS1PfGDANftdnJchuL-WPpSv5rmH

🔹CNBC TV18 Digital: https://www.youtube.com/playlist?list=PLjq9mRS1PfGDLhtM8FzErPcjmJRQ4I5cZ

🔹CNBC TV18 Weekend Special: https://www.youtube.com/playlist?list=PLjq9mRS1PfGBHEa5NnoKuUsX5GwxEGuri

🔹CNBC TV18 Next-Gen: https://www.youtube.com/playlist?list=PLjq9mRS1PfGA6roe9q3J9fq_gBIDjX2w7

🔹Overdrive Show: https://www.youtube.com/playlist?list=PLjq9mRS1PfGCnSVjfbWfNCJLrv-CqfGmH

🔹Young Turks: https://www.youtube.com/playlist?list=PLjq9mRS1PfGBZaN1e38X2ZmevnU1e1NJs

🔹Startup Streets: https://www.youtube.com/playlist?list=PLjq9mRS1PfGD3CzrtMr_VJRbIly6sfyFI

------------------------------------------------------------------------------------
You can also connect with CNBC-TV18 News Online
Catch the latest news: https://bit.ly/2YbpXBM

Follow CNBC-TV18 round the clock: https://www.cnbctv18.com/live-tv/

Stay updated with all the market action in real time: https://www.cnbctv18.com/market-live/

You can also stay updated with all the latest news on-the-go with CNBC-TV18 Minis: https://www.cnbctv18.com/minis/

Like us on Facebook: https://www.facebook.com/cnbctv18india/
Follow us on Twitter: https://twitter.com/CNBCTV18News
Follow us on Instagram: https://www.instagram.com/cnbctv18india/
Catch us on: Linkedin: https://in.linkedin.com/company/cnbc-tv18
n18oc_business

About CNBC-TV18: India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. Catch all your favourite shows, exclusive videos, big-ticket interviews and more here.

Shilpa Medicare's Key CDMO Customer Shows Positive Clinical Results For A Kidney Disease Drug

Shilpa Medicare (SML) surged 16.25% to Rs 657.30 after the company’s CDMO customer, Unicycive Therapeutics, Inc. has reported positive results from pivotal clinical trial of Oxylanthanum Carbonate (OLC) to treat kidney diseases.

Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC

Ahluwalia Contracts (India) Ltd, Shilpa Medicare Ltd, BEML Ltd and Marksans Pharma Ltd are among the other gainers in the BSE’s ‘A’ group today, 05 July 2024.

Raymond Ltd leads gainers in ‘A’ group

Shilpa Medicare hit a multi-year high of Rs 672.50, rallied 16% after the company’s CDMO customer reported positive results from pivotal clinical trial & placed binding purchase order.

This pharma stock has surged 16% on Friday; zoomed over 100% so far in CY24

Shares of the company rose as much as 4.89%, before paring gains to trade 1.76% higher at 10:51 a.m.

Shilpa Medicare Shares Jump 5% On Oral Drug Delivery System Nod

Buzzing stocks of Automobile cos, Maruti Suzuki, Spandana Sphoorty, Bandhan Bank PowerGrid, RVNL, Easemytrip, South Indian Bank, Anupam Rasayan, Aptus Value, Cholamandalam Finance, Escorts, GMDC, Godrej Agro, TTK Health, Tracxn Tech, TBZFredun Pharma, Shilpa Medicare, Greenply, Navin Fluorine, Canta…

Stocks to watch on August 1, 2023

✨PNB, Shilpa Medicare और Tata Consumer समेत आज कौनसे शेयर रहेंगे फोकस में?  

HMA एग्रो का IPO अब तक कितना भरा?

किन खबरों के दम पर #stockmarket  में रहेगा एक्शन? जानिए #stocksinnews  में...

#stockmarket  #stockstowatch  #zeebusiness #investment 

📺Zee Business LIVE- https://bit.ly/3PuiKZ2



About Zee Business:

Zee Business is India's Number 1 Hindi business news channel. It's your channel for profit and wealth. Watch Live coverage of Indian markets - Sensex & Nifty, also for expert insights and advise from our team of experts.
 
--------------------------------------------------------------
Subscribe Zee Business: https://bit.ly/3L6GG0C
 
You Can Also Visit Our Website at: 

Zee Business: https://www.zeebiz.com/
Zee News: https://zeenews.india.com/
DNA India:-https://www.dnaindia.com/
WION: https://www.wionews.com/ 

Follow Us On: 
  
Facebook: https://goo.gl/OMJgrn
Twitter: https://goo.gl/OjOzpB 
Download Zee News App : https://bit.ly/ZeeNewsApps

Stock Market Buzz: PNB, Shilpa Medicare, Tata Consumer | Latest Stock Updates! | Stocks In News

Stocks to watch out for today: HDFC AMC, Shilpa Medicare, BEL, Tata Motors, Shriram Finance, Pidilite and more

Stocks in news: Tata Motors, HDFC AMC, Shriram Finance, Pidilite and more

An expansion in the formulation business, new product pipeline and the monetisation of certain verticals are seen as the major growth triggers for Shilpa Medicare

Shilpa Medicare to consider rights issue on June 23

Price return has been average, nothing exciting

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is underpriced and is not in the overbought zone

Current price is less than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

The stock has a moderate number of red flags

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Shilpa Medicare Limited is engaged in the business of manufacturing of bulk drugs or active pharmaceutical ingredient (API) and intermediates, and wind power generation.